Post-Marketing Surveillance/Late-Phase

Post-Marketing Surveillance/Late-Phase

The DCRI provides the insight, experience, and efficiency to optimize your research investment. Our late-phase clinical trials teams understand that there are many study and design variables and will align and customize their processes to deliver cost-effective results that meet your objectives.


Our teams include specially trained and dedicated project managers as well as experts in health outcomes, epidemiology, biostatistics, and post-marketing regulations.

For all of our projects, we apply multidisciplinary, data-driven study design and recruitment methodologies, flexible delivery models, and proven processes.

Our services include:

  • Post-marketing safety surveillance
  • Additional indication or label expansion trials
  • Comparative effectiveness studies and outcomes research
  • Observational studies; registries
  • Risk management programs
contextual photo